Loading...
XJPX
3101
Market cap952mUSD
Jul 10, Last price  
1,727.00JPY
1D
-1.48%
1Q
16.85%
Jan 2017
-0.75%
Name

Toyobo Co Ltd

Chart & Performance

D1W1MN
XJPX:3101 chart
P/E
13.64
P/S
0.36
EPS
126.63
Div Yield, %
2.28%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
4.55%
Revenues
421.56b
-0.11%
426,666,000,000431,417,000,000367,271,000,000318,773,000,000340,573,000,000349,505,000,000339,009,000,000351,577,000,000351,279,000,000347,763,000,000329,487,000,000331,148,000,000336,698,000,000339,607,000,000337,406,000,000375,720,000,000399,921,000,000414,265,000,000422,032,000,000421,563,000,000
Net income
11.17b
+457.86%
13,472,000,0004,698,000,000-12,505,000,0002,094,000,0004,155,000,0004,587,000,0007,639,000,0008,154,000,0008,117,000,00010,150,000,0009,444,000,00013,043,000,000-603,000,00013,774,000,0004,202,000,00012,865,000,000-655,000,0002,455,000,0002,003,000,00011,174,000,000
CFO
43.26b
+51.15%
25,485,000,00027,724,000,000-1,767,000,00027,381,000,00032,153,000,00013,181,000,00029,480,000,00022,885,000,00019,150,000,00031,541,000,00026,401,000,00021,936,000,0007,475,000,00043,689,000,00034,398,000,00016,540,000,0006,981,000,00020,893,000,00028,624,000,00043,264,000,000
Dividend
Mar 30, 202640 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Osaka, Japan, Toyobo Co., Ltd. is a global enterprise, established in 1882, that specializes in a broad spectrum of advanced materials and products. Its core operations encompass films, functional polymers, industrial materials, healthcare solutions, and textiles. The company's extensive film portfolio features high-performance industrial films, including PET films specifically engineered for liquid crystal displays, optical applications, and various other industrial uses, along with synthetic papers. For the packaging sector, Toyobo supplies a range of materials such as PET, polyolefin, and nylon films, commonly used for food preservation, as well as heat-shrink PET films. Its functional polymers division offers a comprehensive suite of products, including engineering plastics, industrial adhesives, protective coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials. Additionally, Toyobo is involved in rubber and coat processing and produces intermediates for pharmaceutical manufacturing. In the realm of advanced fibers and textiles, the company develops specialized functional fibers, such as those integrated into airbag fabrics, high-strength polyethylene and PBO fibers, and functional filters designed for automotive, indoor air quality, and anti-pollution solvent adsorption, alongside fiber materials for automobile components. Its textile offerings further include performance fabrics for sports apparel, intimate wear, and uniforms, alongside synthetic filaments. Toyobo also markets branded apparel (Munsingwear), acrylic fibers (Exlan), and acrylate fibers (eks), in addition to engaging in general textile trading. The bio-products segment focuses on healthcare and scientific research, providing enzymes for diagnostic purposes, complete diagnostic systems, and reagents for research. This division also manufactures critical medical components like artificial kidney hollow fibers and anti-clotting materials, alongside modules for seawater desalination. Beyond its diverse manufacturing activities, Toyobo also serves as a contract manufacturer for injectable pharmaceutical products.
IPO date
May 16, 1949
Employees
10,885
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT